The fellow will develop expertise in 3 core areas: cutaneous malignancies, skin toxicities of anti-cancer treatments, and cutaneous medical oncology. The program will include the full spectrum of clinical management, from clinical diagnosis to histopathological confirmation and surgery and chemotherapeutic treatments for a wide range of cutaneous malignancies including melanoma, high-risk basal and squamous cell cancers, and rare skin cancers such as Merkel cell carcinoma and other cutaneous malignancies. A multi-disciplinary approach will be utilized, and the fellow will primarily work closely with dermatologists and medical oncologists as well as with dermatopathologists, radiation oncologists, and surgical oncologists. In addition to dermatology, the fellow will also work with medical oncology directly in several clinics to learn indications, how to work-up and manage systemic treatments for cutaneous malignancies with an emphasis on immunotherapy, and targeted therapies. Equally important, the fellow will develop an expertise in identifying, diagnosing, and managing skin toxicities of anticancer treatment with a particular focus on immunotherapies.
